Infections and cancer

Laia Alemany Vilches

PRINCIPAL INVESTIGATORS
  • Francesc Xavier Bosch Jose
  • Laia Bruni Coccoz
  • Miguel Angel Pavon Ribas
  • Raquel Ibañez Pérez
  • Laura Costas Caudet
  • Assumpta Company Serrat
  • Delphine Casabonne
CLINICAL RESEARCHERS
  • Maria Brotons Agulló
  • Maria Eulalia Fernandez Montoli
POSTDOCTORAL RESEARCHERS
  • Marisa Mena Cervigón
  • Beatriz Quirós Blasco
  • Mireia Díaz Sanchís
  • Claudia Robles Hellin
  • Álvaro Carmona Pestaña
  • Ginesa Albero Abril
  • Sònia Paytubi Casabona
PREDOCTORAL RESEARCHERS
  • David Gómez Guillén
  • Jon Frias Gomez
  • Beatriz Serrano Carro
  • Maryam Choulli Amgait
  • Paula Àngela Peremiquel Trillas
  • Alvaro De Andres Pablo
SCIENTIFIC SUPPORT
  • Francisco Javier Ruiz Carrasco
  • Olga Romero Clara
  • Joan Valls Marsal
  • Frederic Rodilla Pamies
  • Jesus Muñoz Villanueva
  • Maria Gema Carretero Garcia
  • Sara Hermosa Garcia
  • Juan José Collado Contreras
  • Ainhoa Botella Cayuelas
  • Victoria Lopez Codony
  • Maria Del Pilar Vidaurre Teixidó
  • Yolanda Florencia Melgarejo
  • Francisca Morey Cortes
  • Vanesa Camon Melguizo
  • Alexandra Montoliu Gimenez
  • Sara Tous Belmonte
  • Laura Monfil Herrera
  • Laura Asensio Puig
  • Esther Roura Fornells
  • Ana Esteban Miró
  • Marleny Vergara Muñoz
  • Yolanda Benavente Moreno
  • Irene Onieva Hernandez
  • Victoria Porthé Reggiardo
  • Antonio Sanchez Baos
  • Beatriz Thais Pelegrina Sanchez-Dehesa
  • Omar Clavero Carletti
  • Valentina Rangel Sarmiento
MANAGEMENT SUPPORT
  • Maite Carvajal Restoy
  • Marta Lopez Querol
  • Natividad Paton Morales
  • Diana Salinas Hidalgo
  • Mireia Montserrat Moreno
  • Arnau Guasch Girbau
Cancer
EPIBELL

Scientific production

30

PAPERS

Average IF: 8,835

11

LED PAPERS

Average IF: 10,58

10 PUBLICATIONS IN FIRST DECILE

24 PUBLICATIONS IN FIRST QUARTILE

21 PUBLICATIONS IN OPEN ACCESS

Selected publications

  • Mehanna,H;Taberna,M;von Buchwald,C;Tous,S;Brooks,J;Mena,M;Morey,F et al, Prognostic implications of p16 and HPV discordance in oropharyngeal cancer (HNCIG-EPIC-OPC): a multicentre, multinational, individual patient data analysis, Lancet Oncol., 2023;24(3):239-251, doi:10.1016/S1470-2045(23)00013-X
  • Bruni,L;Albero,G;Rowley,J;Alemany,L;Arbyn,M;Giuliano,AR;Markowitz,LE et al, Global and regional estimates of genital human papillomavirus prevalence among men: a systematic review and meta-analysis, Lancet Glob. Health, 2023;11(9):1345-1362, doi:10.1016/S2214-109X(23)00305-4
  • Costas,L;Onieva,I;Pelegrina,B;Marin,F;Carmona,A;López Querol,M;Frias Gomez,J et al, Evaluation of Somatic Mutations in Urine Samples as a Noninvasive Method for the Detection and Molecular Classification of Endometrial Cancer, Clin. Cancer Res., 2023;29(18):3681-3690, doi:10.1158/1078-0432.CCR-23-0367
  • Pelegrina,B;Paytubi,S;Marin,F;Martinez,JM;Carmona,A;Frias Gomez,J;Peremiquel Trillas,P et al, Evaluation of somatic mutations in cervicovaginal samples as a non-invasive method for the detection and molecular classification of endometrial cancer, EBioMedicine, 2023;94104716-104716, doi:10.1016/j.ebiom.2023.104716
  • Frias Gomez,J;Alemany,L;Benavente,Y;Clarke,MA;de Francisco,J;De Vivo,I;Du,M et al, Night shift work, sleep duration and endometrial cancer risk: A pooled analysis from the Epidemiology of Endometrial Cancer Consortium (E2C2)., Sleep Med Rev, 2023;72101848-101848, doi:10.1016/j.smrv.2023.101848

Research highlights

PROJECTS

7 Granted competitive projects
22 Ongoing competitive projects

1 Started clinical trial
5 Ongoing clinical trials
2 Ongoing non-competitive projects

NETWORKS

AGAUR SGR GRC
CIBERESP

 

Selected projects

  • CEE21039. PERCH: PartnERship to Contrast HPV. COMISSIÓ EUROPEA. Budget: 409.468,03€. 2022-2025. PI: Brotons Agulló, Maria.
  • 20CEE006. RISCC: RISK-BASED SCREENING FOR CERVICAL CANCER. COMISSIÓ EUROPEA. Budget: 378.125€. 2020-2024. PI: Bosch José, Francesc Xavier.
  • 19CEE002. HEADSpAcE: Translational studies of HEAD and neck cancer in South America and Europe. COMISSIÓ EUROPEA. Budget: 249.985€. 2019-2024. PI: Alemany Vilches, Maria Eulalia.
  • 19ACL260. ENSAYO CLÍNICO EN FASE 3, INTERNACIONAL, MULTICÉNTRICO, ALEATORIZADO, DOBLE CIEGO Y CONTROLADO CON PLACEBO PARA ESTUDIAR LA EFICACIA, LA INMUNOGENICIDAD Y LA SEGURIDAD DE LA VACUNA 9VVPH, UNA VACUNA POLIVALENTE DE PARTÍCULAS VIROIDES L1, EN LA PREVENCIÓN DE LA INFECCIÓN BUCAL PERSISTENTE POR LOS TIPOS 16, 18, 31, 33, 45, 52 O 58 DEL VPH EN VARONES ADULTOS DE 20 A 45 AÑOS DE EDAD. MERCK SHARP & DOHME ESPAÑA S.A. Budget: 224.455€. 2020- . PI: Alemany Vilches, Maria Eulalia.
  • MCI22005. WOMEC ADVANCED : NUEVAS APROXIMACIONES PARA EL DIAGNÓSTICO DE CÁNCER DE ENDOMETRIO. Ministerio de Ciencia e Innovación. Budget: 194.288€. 2022-2025. PI: Costas Caudet, Laura.